Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 25, 2025 08:31 ET | Source: Genelux Corporation

Genelux Corporation Announces Pricing of $10.5 Million Underwritten Offering of Common Stock

WESTLAKE VILLAGE, Calif., March 25, 2025 (GLOBE NEWSWIRE) -- Genelux Corporation (“Genelux”) (Nasdaq: GNLX), a late clinical-stage immuno-oncology company, today announced the pricing of an...
May 24, 2024 08:00 ET | Source: Genelux Corporation

Genelux Corporation Announces Pricing of Approximately $27.5 Million Underwritten Offering of Common Stock and Accompanying Warrants

Genelux Corporation Announces Pricing of Approximately $27.5 Million Underwritten Offering of Common Stock and Accompanying Warrants
May 23, 2024 16:01 ET | Source: Genelux Corporation

Genelux Corporation Announces Proposed Public Offering of Common Stock and Warrants

Genelux Corporation Announces Proposed Public Offering of Common Stock and Warrants
June 12, 2023 07:00 ET | Source: Genelux Corporation

Genelux Corporation Announces $18 Million Private Placement

WESTLAKE VILLAGE, Calif., June 12, 2023 (GLOBE NEWSWIRE) -- Genelux Corporation (NASDAQ: GNLX), a late clinical-stage immuno-oncology company, today announced a private placement for 900,000 shares...
May 15, 2023 07:00 ET | Source: Genelux Corporation

Genelux Corporation Announces $33 Million Private Placement

WESTLAKE VILLAGE, Calif., May 15, 2023 (GLOBE NEWSWIRE) -- Genelux Corporation (NASDAQ: GNLX), a late clinical-stage immuno-oncology company, today announced a private placement of 1,665,247 shares...